| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | Director | Common Stock | 17,523 | $100,582 | $5.74 | 21 May 2024 | Direct |
| Aurinia Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 15,234 | 19 May 2023 | Direct | ||
| Aurinia Pharmaceuticals Inc. | Director | Restricted Stock Units | 0 | 18 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 21 May 2024 | 1 | -$2,985 | 4 | Director | 22 May 2024, 16:16 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 May 2023 | 4 | $0 | 4 | Director | 23 May 2023, 17:22 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 May 2022 | 2 | $0 | 4 | Director | 20 May 2022, 16:07 |
| AUPH | Aurinia Pharmaceuticals Inc. | 14 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 16:39 |
| AUPH | Aurinia Pharmaceuticals Inc. | 14 Jun 2021 | 0 | $0 | 3 | Director | 17 Jun 2021, 16:37 |